Brodalumab for severe hidradenitis suppurativa: a case of clinico-radiologic improvement and literature review
Hidradenitis suppurativa (HS) is a chronic autoinflammatory follicular disease, affecting body areas that are rich in apocrine glands. Moderate-to-severe HS may severely impair patients’ quality of life also because the available therapies are often unsatisfactory. Several lines of evidence suggest...
Main Authors: | Emanuele Vagnozzi, Manfredo Bruni, Maria Esposito, Maria Concetta Fargnoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2023.2270091 |
Similar Items
-
IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa
by: Dalma Malvaso, et al.
Published: (2023-10-01) -
Brodalumab
by: Murat Borlu
Published: (2022-04-01) -
Multimodal management of hidradenitis suppurativa
by: Gregor B.E. Jemec, MD, DMSc
Published: (2020-06-01) -
Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn’s disease
by: Hannah S. Berman, et al.
Published: (2021-02-01) -
New and Emerging Targeted Therapies for Hidradenitis Suppurativa
by: Adela Markota Čagalj, et al.
Published: (2022-03-01)